Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 04, 2019

SELL
$10.72 - $16.73 $131,630 - $205,427
-12,279 Closed
0 $0
Q3 2018

Oct 15, 2018

SELL
$17.73 - $26.69 $7,889 - $11,877
-445 Reduced 3.5%
12,279 $292,000
Q1 2018

Apr 16, 2018

BUY
$9.0 - $20.16 $2,223 - $4,979
247 Added 1.98%
12,724 $142,000
Q4 2017

Jan 31, 2018

BUY
$13.26 - $22.86 $165,445 - $285,224
12,477
12,477 $242,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $423M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Malaga Cove Capital, LLC Portfolio

Follow Malaga Cove Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Malaga Cove Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Malaga Cove Capital, LLC with notifications on news.